Literature DB >> 26563401

Interobserver reproducibility in pathologist interpretation of columnar-lined esophagus.

Luca Mastracci1,2, Nataniele Piol3,4, Luca Molinaro5, Francesca Pitto3,4, Carmine Tinelli6, Annalisa De Silvestri6, Roberto Fiocca3,4, Federica Grillo3,4.   

Abstract

Confirmation of endoscopically suspected esophageal metaplasia (ESEM) requires histology, but confusion in the histological definition of columnar-lined esophagus (CLE) is a longstanding problem. The aim of this study is to evaluate interpathologist variability in the interpretation of CLE. Thirty pathologists were invited to review three ten-case sets of CLE biopsies. In the first set, the cases were provided with descriptive endoscopy only; in the second and the third sets, ESEM extent using Prague criteria was provided. Moreover, participants were required to refer to a diagnostic chart for evaluation of the third set. Agreement was statistically assessed using Randolph's free-marginal multirater kappa. While substantial agreement in recognizing columnar epithelium (K = 0.76) was recorded, the overall concordance in clinico-pathological diagnosis was low (K = 0.38). The overall concordance rate improved from the first (K = 0.27) to the second (K = 0.40) and third step (K = 0.46). Agreement was substantial when diagnosing Barrett's esophagus (BE) with intestinal metaplasia or inlet patch (K = 0.65 and K = 0.89), respectively, in the third step, while major problems in interpretation of CLE were observed when only cardia/cardia-oxyntic atrophic-type epithelium was present (K = 0.05-0.29). In conclusion, precise endoscopic description and the use of a diagnostic chart increased consistency in CLE interpretation of esophageal biopsies. Agreement was substantial for some diagnostic categories (BE with intestinal metaplasia and inlet patch) with a well-defined clinical profile. Interpretation of cases with cardia/cardia-oxyntic atrophic-type epithelium, with or without ESEM, was least consistent, which reflects lack of clarity of definition and results in variable management of this entity.

Entities:  

Keywords:  Barrett’s esophagus; Columnar-lined esophagus; Histological diagnosis; Interobserver variation

Mesh:

Year:  2015        PMID: 26563401     DOI: 10.1007/s00428-015-1878-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  36 in total

1.  Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.

Authors:  Rebecca Harrison; Ian Perry; William Haddadin; Stuart McDonald; Richard Bryan; Keith Abrams; Richard Sampliner; Nicholas J Talley; Paul Moayyedi; Janusz A Jankowski
Journal:  Am J Gastroenterol       Date:  2007-04-13       Impact factor: 10.864

2.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

3.  Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion.

Authors:  S A McClave; H W Boyce; M R Gottfried
Journal:  Gastrointest Endosc       Date:  1987-12       Impact factor: 9.427

4.  Is there a set of histologic changes that are invariably reflux associated?

Authors:  Kaiyo Takubo; Naoko Honma; Gopi Aryal; Motoji Sawabe; Tomio Arai; Yasuo Tanaka; Ken-ichi Mafune; Katsuhiko Iwakiri
Journal:  Arch Pathol Lab Med       Date:  2005-02       Impact factor: 5.534

5.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.

Authors:  Prateek Sharma; John Dent; David Armstrong; Jacques J G H M Bergman; Liebwin Gossner; Yoshio Hoshihara; Janusz A Jankowski; Ola Junghard; Lars Lundell; Guido N J Tytgat; Michael Vieth
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

Review 6.  Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract.

Authors:  Rhonda K Yantiss; Robert D Odze
Journal:  Am J Gastroenterol       Date:  2009-02-10       Impact factor: 10.864

7.  Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK.

Authors:  A Mandal; R J Playford; A C Wicks
Journal:  Aliment Pharmacol Ther       Date:  2003-05-15       Impact factor: 8.171

8.  Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus.

Authors:  Piers A C Gatenby; James R Ramus; Christine P J Caygill; Neil A Shepherd; Anthony Watson
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

9.  Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy.

Authors:  Jo-Etienne Abela; James J Going; John F Mackenzie; Margaret McKernan; Sylvia O'Mahoney; Robert C Stuart
Journal:  Am J Gastroenterol       Date:  2008-03-26       Impact factor: 10.864

10.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.

Authors:  Rebecca C Fitzgerald; Massimiliano di Pietro; Krish Ragunath; Yeng Ang; Jin-Yong Kang; Peter Watson; Nigel Trudgill; Praful Patel; Philip V Kaye; Scott Sanders; Maria O'Donovan; Elizabeth Bird-Lieberman; Pradeep Bhandari; Janusz A Jankowski; Stephen Attwood; Simon L Parsons; Duncan Loft; Jesper Lagergren; Paul Moayyedi; Georgios Lyratzopoulos; John de Caestecker
Journal:  Gut       Date:  2013-10-28       Impact factor: 23.059

View more
  2 in total

1.  Acceptability and Adequacy of a Non-endoscopic Cell Collection Device for Diagnosis of Barrett's Esophagus: Lessons Learned.

Authors:  Nicholas J Shaheen; Srinadh Komanduri; V Raman Muthusamy; Sachin Wani; Maria O'Donovan; Rajinder Kaushal; John M Haydek
Journal:  Dig Dis Sci       Date:  2021-02-03       Impact factor: 3.199

Review 2.  Gastro-esophageal reflux disease and Barrett's esophagus: an overview with an histologic diagnostic approach.

Authors:  Luca Mastracci; Federica Grillo; Paola Parente; Elettra Unti; Serena Battista; Paola Spaggiari; Michela Campora; Giulia Scaglione; Matteo Fassan; Roberto Fiocca
Journal:  Pathologica       Date:  2020-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.